Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis
F Petrelli1, E Pezzica, M Cabiddu
1Department of Oncology, Division of Medical Oncology, Azienda Ospedaliera Treviglio, Treviglio, BG, Italy, faupe@libero.it.
Tumour budding, a feature in colorectal cancer (CRC), significantly worsens survival in stage II patients. High-grade budding indicates a higher risk of death, potentially guiding adjuvant chemotherapy decisions.
Area of Science:
- Oncology
- Pathology
- Cancer Research
Background:
- Tumour budding, characterized by small malignant cell clusters at the invasive tumor edge, is a recognized negative prognostic factor in colorectal cancer (CRC).
- It is frequently associated with adverse pathological features and poorer patient outcomes.
- The prognostic significance of tumour budding in stage II CRC warrants further investigation.
Purpose of the Study:
- To conduct a meta-analysis evaluating the association between tumour budding and survival in stage II colorectal cancer (CRC) patients.
- To quantify the impact of tumour budding on overall survival (OS) in this patient cohort.
Main Methods:
- A systematic literature search was performed across PubMed, EMBASE, Web of Science, and SCOPUS.
- Data from 12 studies including 1652 patients were analyzed to calculate odds ratios (ORs) for death and hazard ratios (HRs) for survival.
- The Mantel-Haenszel random effect model was employed for data pooling.
Main Results:
- High-grade tumour budding was significantly associated with worse 5-year overall survival (OS) in stage II CRC patients (OR for death: 6.25, P < 0.00001).
- The absolute difference in 5-year OS was -25% for patients with high-grade budding.
- High-grade budding increased the risk of death (HR: 3.68, P < 0.00001).
Conclusions:
- Tumour budding is a significant predictor of worse survival in stage II colorectal cancer (CRC).
- This association is particularly pronounced in pT3N0M0 patients.
- Tumour budding may aid in identifying high-risk, node-negative CRC patients who could benefit from adjuvant chemotherapy.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Survival Analysis
